<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article article-type="case-report" dtd-version="1.0" specific-use="sps-1.8" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">rca</journal-id>
			<journal-title-group>
				<journal-title>Revista Colombiana de Anestesiología</journal-title>
				<abbrev-journal-title abbrev-type="publisher">Rev. colomb. anestesiol.</abbrev-journal-title>
			</journal-title-group>
			<issn pub-type="ppub">0120-3347</issn>
			<publisher>
				<publisher-name>SCARE-Sociedad Colombiana de Anestesiología y Reanimación</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="doi">10.1097/CJ9.0000000000000072</article-id>
			<article-id pub-id-type="publisher-id">00009</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Case report</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Two probable anaphylactic events during consecutive cranial surgeries: case report</article-title>
				<trans-title-group xml:lang="es">
					<trans-title>Dos probables eventos de anafilaxia durante cirugías craneales consecutivas. Reporte de caso</trans-title>
				</trans-title-group>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Ramirez-Gonzales</surname>
						<given-names>Rafael</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>a</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Del-Castillo-Gervasi</surname>
						<given-names>Román Augusto</given-names>
					</name>
					<xref ref-type="aff" rid="aff1_1"><sup>a</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Shiraishi-Zapata</surname>
						<given-names>Carlos Javier</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>b</sup></xref>
					<xref ref-type="corresp" rid="c1"><sup>*</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Laurencio-Ambrosio</surname>
						<given-names>John Neper</given-names>
					</name>
					<xref ref-type="aff" rid="aff1_2"><sup>a</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff1">
				<label>a</label>
				<institution content-type="original"> Department of Anesthesiology and Surgical Center, Hospital María Auxiliadora, Ministry of Health, Lima, Peru.</institution>
				<institution content-type="normalized">Universidad María Auxiliadora</institution>
				<institution content-type="orgdiv1">Department of Anesthesiology and Surgical Center</institution>
				<institution content-type="orgname">Hospital María Auxiliadora</institution>
				<addr-line>
					<named-content content-type="city">Lima</named-content>
				</addr-line>
				<country country="PE">Peru</country>
				<email>Shiraishi52@hotmail.com</email>
			</aff>
			<aff id="aff1_1">
				<label>a</label>
				<institution content-type="original"> Department of Anesthesiology and Surgical Center, Hospital María Auxiliadora, Ministry of Health, Lima, Peru.</institution>
				<institution content-type="normalized">Universidad María Auxiliadora</institution>
				<institution content-type="orgdiv1">Department of Anesthesiology and Surgical Center</institution>
				<institution content-type="orgname">Hospital María Auxiliadora</institution>
				<addr-line>
					<named-content content-type="city">Lima</named-content>
				</addr-line>
				<country country="PE">Peru</country>
			</aff>
			<aff id="aff1_2">
				<label>a</label>
				<institution content-type="original"> Department of Anesthesiology and Surgical Center, Hospital María Auxiliadora, Ministry of Health, Lima, Peru.</institution>
				<institution content-type="normalized">Universidad María Auxiliadora</institution>
				<institution content-type="orgdiv1">Department of Anesthesiology and Surgical Center</institution>
				<institution content-type="orgname">Hospital María Auxiliadora</institution>
				<addr-line>
					<named-content content-type="city">Lima</named-content>
				</addr-line>
				<country country="PE">Peru</country>
			</aff>
			<aff id="aff2">
				<label>b</label>
				<institution content-type="original"> Surgical Center and Anesthesiology Service, Hospital EsSalud, Talara, Peru.</institution>
				<institution content-type="orgdiv1">Surgical Center and Anesthesiology Service</institution>
				<institution content-type="orgname">Hospital EsSalud</institution>
				<addr-line>
					<named-content content-type="city">Talara</named-content>
				</addr-line>
				<country country="PE">Peru</country>
			</aff>
			<author-notes>
				<corresp id="c1">
					<label><sup>*</sup></label> Correspondence: Servicio de Centro Quirárgico y Anestesiología, Hospital EsSalud, Avenida Panamericana s/n Pariñas, Talara, Peru. E-mail: Shiraishi52@hotmail.com</corresp>
			</author-notes>
			<pub-date pub-type="epub-ppub">
				<season>Oct-Dec</season>
				<year>2018</year>
			</pub-date>
			<volume>46</volume>
			<issue>4</issue>
			<fpage>322</fpage>
			<lpage>326</lpage>
			<permissions>
				<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" xml:lang="en">
					<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p>
				</license>
			</permissions>
			<abstract>
				<title>Abstract</title>
				<p>Perioperative anaphylaxis represents a complex diagnosis due to the varying intensity of the symptoms which are also shared with other pathologies. This article discusses a case of a patient that sustained 2 probable anaphylactic reactions during consecutive cranial surgeries under general anesthesia; the causal agent could not be confirmed. Investigating these reactions is essential for identifying the causal agents and preventing increasingly severe reactions in future exposures.</p>
			</abstract>
			<trans-abstract xml:lang="es">
				<title>Resumen</title>
				<p>La anafilaxia perioperatoria representa un diagnóstico problemático porque posee manifestaciones clínicas de distinta intensidad y comunes a otras patologías. Reportamos el caso de un paciente que presentó dos probables eventos de anafilaxia durante cirugías craneales consecutivas bajo anestesia general, cuyo agente causal no pudo ser confirmado. La investigación de estas reacciones es crucial para identificar los agentes causales y evitar reacciones de mayor severidad en futuras exposiciones.</p>
			</trans-abstract>
			<kwd-group xml:lang="en">
				<title>Keywords:</title>
				<kwd>Anesthesia</kwd>
				<kwd>Anaphylaxis</kwd>
				<kwd>Heart Arrest</kwd>
				<kwd>Cardiopulmonary</kwd>
			</kwd-group>
			<kwd-group xml:lang="es">
				<title>Palabras clave:</title>
				<kwd>Anestesia</kwd>
				<kwd>Anafilaxia</kwd>
				<kwd>Paro Cardíaco</kwd>
				<kwd>Reanimación</kwd>
			</kwd-group>
			<counts>
				<fig-count count="0"/>
				<table-count count="3"/>
				<equation-count count="0"/>
				<ref-count count="20"/>
				<page-count count="5"/>
			</counts>
		</article-meta>
	</front>
	<body>
		<sec sec-type="intro">
			<title>Introduction</title>
			<p> Anaphylaxis is a systemic life-threatening hypersensitivity reaction (HR).<xref ref-type="bibr" rid="B1"><sup>1</sup></xref> Perioperative anaphylaxis is among the main causes of anesthetic complications, with an incidence rate of 1/1250 to 1/18,600 procedures and a mortality rate between 4% and 4.7% (pharmacological anaphylaxis).<xref ref-type="bibr" rid="B2"><sup>2</sup></xref> It is caused by the stimulus of bioactive mediators releasing mast cells and basophils, in 2 or more body systems, resulting in increased capillary permeability, vasodilatation, bronchoconstriction, and hypotension.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref>
			</p>
			<p>Intraoperative anaphylaxis is a complex diagnosis as several symptoms cannot be evaluated in a sedated or unconscious patient, the cutaneous signs are hidden under the surgical drapes, and several drugs are administered simultaneously.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B4"><sup>4</sup></xref> A total of 90% of the cases develop during induction, although there are late reactions as well, and the symptoms exhibit varying intensities, ranging from mild HRs with a preponderance of cutaneous manifestations (grade I) to cardiac and/or respiratory arrest (grade IV).<xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref> In the presence of only 1 symptom, intraoperative anaphylaxis may be misdiagnosed, in addition to the lack of an evaluation by the allergy clinic, and the risk of a new-potentially lethal -exposure to the agent involved.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref>
			</p>
			<p>The most frequent signs in the presence of adverse reactions are the absence of pulse, difficult ventilation from bronchospasm, desaturation, and even cardiovascular collapse or cardiac arrest as the primary manifestation.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref> The reduction in end-tidal CO<sub>2</sub> (ETCO<sub>2</sub>) below 20mm Hg has also been considered a valuable marker.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref>
			</p>
		</sec>
		<sec>
			<title>Patient information</title>
			<p>A 44-year-old male patient from a rural area, admitted to the intermediate care unit following his discharge from the intensive care unit (ICU), as a result of supraventricular tachycardia (SVT) over an elective cranial surgery which led to the interruption of the procedure (<xref ref-type="table" rid="t1">Table 1</xref>). A mild right hemiparesis was identified in the patient on clinical examination. The cardiology evaluation failed to identify any alteration and concluded that the SVT was the result of surgical manipulation or autonomic reflex. An amount of 10 mg of propanolol b.i.d. were prescribed, with a Goldman 2 index classification. No allergies (neither food nor drugs) were reported during the anesthetic evaluation and the patient was classified as American Society of Anesthesiologists (ASA) class 2 and was rescheduled.</p>
			<p>
				<table-wrap id="t1">
					<label>Table 1</label>
					<caption>
						<title>Timeline.</title>
					</caption>
					<graphic xlink:href="0120-3347-rca-46-04-322-gt1.png"/>
					<table-wrap-foot>
						<fn id="TFN1">
							<p>CP=cranioplasty, CPR=cardiopulmonary resuscitation, DC=decompressive craniotomy, ICU=intensive care unit, IMCU=intermediate care unit, PACU=postanesthesia care unit, PEA=pulseless electrical activity, SVT=supraventricular tachycardia, TBI=traumatic brain injury.</p>
						</fn>
						<fn id="TFN2">
							<p>Source: Authors.</p>
						</fn>
					</table-wrap-foot>
				</table-wrap>
			</p>
		</sec>
		<sec>
			<title>Clinical findings</title>
			<p>The patient was admitted to the OR with normal vital signs and 95 kg of body weight. Balanced anesthesia was administered for induction (<xref ref-type="table" rid="t1">Tables 1</xref> and <xref ref-type="table" rid="t2">2</xref>) and endotracheal intubation was performed with a No. 8.5 endotracheal intubation tube (ETT). The surgical procedure began with a 99% oxygen saturation (SpO2) and 30mm Hg of ETCO2. Vital signs were normal during maintenance. One hour after induction, suddenly and with no previous blood pressure (hypotension) or heart rate (bradycardia) alterations, sustained and progressive declines in ETCO2 and SpO<sub>2</sub> (down to 24 mm Hg and 92%, respectively) were recorded.</p>
			<p>
				<table-wrap id="t2">
					<label>Table 2</label>
					<caption>
						<title>Detailed list of drugs used in the 3 surgical procedures.</title>
					</caption>
					<graphic xlink:href="0120-3347-rca-46-04-322-gt2.png"/>
					<table-wrap-foot>
						<fn id="TFN3">
							<p>CP=cranioplasty, DC=decompressive craniotomy, PEA=pulseless electrical activity, SVT=supraventricular tachycardia.</p>
						</fn>
						<fn id="TFN4">
							<p>Source: Authors.</p>
						</fn>
					</table-wrap-foot>
				</table-wrap>
			</p>
		</sec>
		<sec>
			<title>Diagnostic evaluation</title>
			<p>Due to the alterations in ETCO<sub>2</sub> and SpO<sub>2</sub>, malfunction of the ETT device was ruled out initially. Immediately after, the absence of palpable pulse and SVT was identified in the multiparameter monitor, with signs of pulseless electrical activity (PEA). Furthermore, when removing the surgical drapes, generalized edema was evidenced and consequently the patient was diagnosed with probable grade IV anaphylaxis.</p>
		</sec>
		<sec>
			<title>Therapeutic intervention</title>
			<p>Advanced cardiopulmonary resuscitation (CPR) was initiated with continuous chest compressions, IV administration of 1 mg of adrenalin and manual ventilation. Two minutes later, return of spontaneous circulation (ROSC) developed and the compressions were discontinued. However, they had to be reinitiated 1 minute later because of ventricular fibrillation (VF) requiring a 200 joules biphasic shock. A second dose of adrenaline was administered. The VF relapsed on 3 occasions and the same treatment was repeated. After 2 minutes, ROSC was confirmed and a subclavian venous catheter and a radial arterial catheter were placed.</p>
		</sec>
		<sec>
			<title>Follow-up and results</title>
			<p>The patient was admitted to the postanesthesia care unit with 70/50 mm Hg of invasive arterial pressure, 130 bpm, 90% SpO<sub>2</sub>, central venous pressure of 10cmH<sub>2</sub>O, under volume controlled mechanical ventilation and dopamine at adjustable dose. 250mg of hydrocortisone t.i.d. were administered 10hours after PEA, and the patient was extubated without any complications with a Glasgow score of 14 points, 15 hours later. The patient was then transferred to the intermediate care unit where dopamine was then withdrawn after 3 days and 6 days later was transferred to the general hospitalization floor from where he was finally discharged.</p>
		</sec>
		<sec sec-type="discussion">
			<title>Discussion</title>
			<p>The intermediate care unit evaluation focused on the SVT that led to the interruption of surgery because of an initial suspicion of cardiac pathology. However, the medical record indicated that the patient was admitted to the ICU following distributive shock resulting from anaphylaxis secondary to an adverse drug reaction (ADR), with hypotension and generalized erythema. Consequently, this first event was probably consistent with grade III anaphylaxis.</p>
			<p>The primary cause of perioperative HRs is neuromuscular relaxants (NMRs) (50% to 70%), followed by latex (12% to 16.7%), and antibiotics (15%).<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref> Reviewing the role of the various drugs administered over surgery in the case of immediate HRs (<xref ref-type="table" rid="t2">Table 2</xref>), sodium thiopental is often involved (incidence 1:30,000), although propofol may also be the culprit. Midazolam (administered in 2 surgeries) and fentanyl (administered in all of them) rarely trigger these reactions.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref>
			</p>
			<p>Two steroid monoquaternary compounds were used (Rocuronium and Vecuronium), with replaced ammonia ions. These ions represent allergenic sites involved in the specific immunoglobulin E (IgE) recognition which could explain the crossed reactivity (CR) in skin tests of 60% to 70% of patients allergic to NMRs. CR to all relaxants is more frequent when a steroid compound triggered the initial reaction. There were also HRs in NMRs-naive patients because there is CR with cosmetics, foods, and disinfectants.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref>
			</p>
			<p>Other late intraoperative anaphylaxis-causing agents are iodine povidone and chlorhexidine.<xref ref-type="bibr" rid="B10"><sup>10</sup></xref> In a previous report<xref ref-type="bibr" rid="B11"><sup>11</sup></xref> Naranjo's algorithm was used to assess the causality of an ADR. This algorithm enabled the analysis of a second HR, with a score of 5 for the relaxant and povidone, which makes them potential ADR agents.<xref ref-type="bibr" rid="B12"><sup>12</sup></xref> Considering that few cases were reported in response to topical povidone, the NMR would then be the causal agent.<xref ref-type="bibr" rid="B13"><sup>13</sup></xref>
			</p>
			<p>Investigating the cause of anaphylaxis may be complex, since there may be several agents involved.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref> 3 necessary evidences have been described: medical record, biological evaluation, and skin tests.<xref ref-type="bibr" rid="B14"><sup>14</sup></xref> The biological evaluation identifies the presence of an allergic mechanism in the reaction through early laboratory tests (total tryptase blood test and plasma histamine) and late laboratory tests (prick test, basophil activation, challenge tests, and specific IgE immunoassays).<xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B14"><sup>14</sup></xref> In this 2 potential anaphylactic events, only clinical evidence was available. Moreover, the availability of the other tests required in our setting at the time of presentation is unclear.</p>
			<p>The critical situation was neglecting the first HR since the patient should have been evaluated by the allergy clinic and the procedure rescheduled, once the agent involved was identified. Failure to do so led to a new exposure to the agent, resulting in a more severe preventable reaction.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B15"><sup>15</sup></xref> Actually, every perioperative reaction must be investigated to ensure safe anesthetic procedures in the future, because even a mild reaction may be due to hypersensitivity and hence be neglected or attributed to unspecific reactions.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref>
			</p>
			<p>Some therapeutic approaches to these potential HRs may be optimized; for instance, administering IV fluid challenges, Chlorphenamine and Amiodarone (to avoid the relapse of atrial fibrillation)<xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref> (<xref ref-type="table" rid="t3">Table 3</xref>). The value of the acronym dislodgement, obstruction, suspected pneumothorax and equipment or operator problem (DOPE) has been recognized to address the deterioration of the patient in mechanical ventilation.<xref ref-type="bibr" rid="B20"><sup>20</sup></xref>
			</p>
			<p>
				<table-wrap id="t3">
					<label>Table 3</label>
					<caption>
						<title>Differential diagnosis and management of perioperative anaphylaxis in the adult.</title>
					</caption>
					<graphic xlink:href="0120-3347-rca-46-04-322-gt3.png"/>
					<table-wrap-foot>
						<fn id="TFN5">
							<p>CPR=cardiopulmonary resuscitation, FI0<sub>2</sub> = fraction of inspired oxygen, PEEP=positive end-expiratory pressure, ROSC=return of spontaneous circulation. Adapted from Chapman and Lalkhen,<xref ref-type="bibr" rid="B1"><sup>1</sup></xref> Mertes et al,<xref ref-type="bibr" rid="B6"><sup>6</sup></xref> and McEvoy et al.<xref ref-type="bibr" rid="B19"><sup>19</sup></xref>
							</p>
						</fn>
						<fn id="TFN6">
							<p>Source: Authors.</p>
						</fn>
					</table-wrap-foot>
				</table-wrap>
			</p>
			<p>Following a HR, the anesthesiologist shall request laboratory tests that contribute to a clinical diagnosis, in addition to interconsulting with the allergy clinic to investigate the causal agent. Furthermore, all the Peruvian anesthesiology services nowadays have a mandatory record of adverse events. Finally, the early identification of the disruption in ETCO<sub>2</sub> y SaO<sub>2</sub> enabled the introduction of timely CPR measures to avoid a fatal outcome.</p>
		</sec>
		<sec>
			<title>Patient's opinion</title>
			<p>There were no follow-up anesthesia visits to give the patient a detailed written pharmacological report, and the result of the patient's allergy evaluation is unknown.</p>
		</sec>
		<sec>
			<title>Informed consent</title>
			<p>The Hospital Ethics Committee approved the publication of this case report because the patient is not a resident of the hospital jurisdiction to be able to obtain a written consent.</p>
		</sec>
		<sec>
			<title>Ethical responsibilities</title>
			<p>Protection of persons and animals: The authors declare that the procedures followed were consistent with the ethical standards of the responsible human experimentation committee and pursuant to World Medical Association and the Declaration of Helsinki.</p>
			<p>Confidentiality of the information: The authors state that they have followed the institutional protocols regarding the publication of patient information.</p>
			<p>Right to privacy and informed consent: The authors have obtained the informed consents of the patients and/ or individuals mentioned herein. The custodian of this document is the corresponding author.</p>
		</sec>
	</body>
	<back>
		<ref-list>
			<title>References</title>
			<ref id="B1">
				<label>1</label>
				<mixed-citation>1. Chapman J, Lalkhen AG. Anaphylaxis. Anaesth Intensive Care Med 2017;18:16-21.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Chapman</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Lalkhen</surname>
							<given-names>AG</given-names>
						</name>
					</person-group>
					<article-title>Anaphylaxis</article-title>
					<source>Anaesth Intensive Care Med</source>
					<year>2017</year>
					<volume>18</volume>
					<fpage>16</fpage>
					<lpage>21</lpage>
				</element-citation>
			</ref>
			<ref id="B2">
				<label>2</label>
				<mixed-citation>2. Mertes PM, Volcheck GW, Garvey LH, et al. Epidemiology of perioperative anaphylaxis. Presse Med 2016;45:758-767.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Mertes</surname>
							<given-names>PM</given-names>
						</name>
						<name>
							<surname>Volcheck</surname>
							<given-names>GW</given-names>
						</name>
						<name>
							<surname>Garvey</surname>
							<given-names>LH</given-names>
						</name>
					</person-group>
					<article-title>Epidemiology of perioperative anaphylaxis</article-title>
					<source>Presse Med</source>
					<year>2016</year>
					<volume>45</volume>
					<fpage>758</fpage>
					<lpage>767</lpage>
				</element-citation>
			</ref>
			<ref id="B3">
				<label>3</label>
				<mixed-citation>3. Kannan JA, Bernstein JA. Perioperative anaphylaxis: diagnosis, evaluation and management. Immunol Allergy Clin North Am 2015;35:321-334.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Kannan</surname>
							<given-names>JA</given-names>
						</name>
						<name>
							<surname>Bernstein</surname>
							<given-names>JA</given-names>
						</name>
					</person-group>
					<article-title>Perioperative anaphylaxis diagnosis, evaluation and management</article-title>
					<source>Immunol Allergy Clin North Am</source>
					<year>2015</year>
					<volume>35</volume>
					<fpage>321</fpage>
					<lpage>334</lpage>
				</element-citation>
			</ref>
			<ref id="B4">
				<label>4</label>
				<mixed-citation>4. Peroni DG, Sansotta N, Bernardini R, et al. Perioperative allergy: clinical manifestations. Int J Immunopathol Pharmacol 2011;24 (3 suppl):S69-S74.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Peroni</surname>
							<given-names>DG</given-names>
						</name>
						<name>
							<surname>Sansotta</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Bernardini</surname>
							<given-names>R</given-names>
						</name>
					</person-group>
					<article-title>Perioperative allergy clinical manifestations</article-title>
					<source>Int J Immunopathol Pharmacol</source>
					<year>2011</year>
					<volume>24</volume>
					<issue>3 Suppl</issue>
					<fpage>S69</fpage>
					<lpage>S74</lpage>
				</element-citation>
			</ref>
			<ref id="B5">
				<label>5</label>
				<mixed-citation>5. Moneret-Vautrin DA, Mertes PM. Anaphylaxis to general anesthetics. Chem Immunol Allergy 2010;95:180-189.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Moneret-Vautrin</surname>
							<given-names>DA</given-names>
						</name>
						<name>
							<surname>Mertes</surname>
							<given-names>PM</given-names>
						</name>
					</person-group>
					<article-title>Anaphylaxis to general anesthetics</article-title>
					<source>Chem Immunol Allergy</source>
					<year>2010</year>
					<volume>95</volume>
					<fpage>180</fpage>
					<lpage>189</lpage>
				</element-citation>
			</ref>
			<ref id="B6">
				<label>6</label>
				<mixed-citation>6. Mertes PM, Tajima K, Regnier-Kimmoun MA, et al. Perioperative anaphylaxis. Med Clin N Am 2010;94:761-789.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Mertes</surname>
							<given-names>PM</given-names>
						</name>
						<name>
							<surname>Tajima</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Regnier-Kimmoun</surname>
							<given-names>MA</given-names>
						</name>
					</person-group>
					<article-title>Perioperative anaphylaxis</article-title>
					<source>Med Clin N Am</source>
					<year>2010</year>
					<volume>94</volume>
					<fpage>761</fpage>
					<lpage>789</lpage>
				</element-citation>
			</ref>
			<ref id="B7">
				<label>7</label>
				<mixed-citation>7. Gouel-Chéron A, de Cahisemartin L, Jonsson F, et al. Low end-tidal CO2 as a real-time severity marker of intra-anaesthetic acute hypersensitivity reactions. Br J Anaesth 2017;119:908-917.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Gouel-Chéron</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>de Cahisemartin</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Jonsson</surname>
							<given-names>F</given-names>
						</name>
					</person-group>
					<article-title>Low end-tidal CO2 as a real-time severity marker of intra-anaesthetic acute hypersensitivity reactions</article-title>
					<source>Br J Anaesth</source>
					<year>2017</year>
					<volume>119</volume>
					<fpage>908</fpage>
					<lpage>917</lpage>
				</element-citation>
			</ref>
			<ref id="B8">
				<label>8</label>
				<mixed-citation>8. Volcheck GW, Mertes PM. Local and general anesthetics immediate hypersensitivity reactions. Immunol Allergy Clin North Am 2014;34:525-546.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Volcheck</surname>
							<given-names>GW</given-names>
						</name>
						<name>
							<surname>Mertes</surname>
							<given-names>PM</given-names>
						</name>
					</person-group>
					<article-title>Local and general anesthetics immediate hypersensitivity reactions</article-title>
					<source>Immunol Allergy Clin North Am</source>
					<year>2014</year>
					<volume>34</volume>
					<fpage>525</fpage>
					<lpage>546</lpage>
				</element-citation>
			</ref>
			<ref id="B9">
				<label>9</label>
				<mixed-citation>9. Naguib M, Lien CA, Meistelman C. Miller RD. Pharmacology of neuromuscular blocking drugs. Miller's anesthesia 8th ed.Elsevier, Canada:2015.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Naguib</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Lien</surname>
							<given-names>CA</given-names>
						</name>
						<name>
							<surname>Meistelman</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Miller</surname>
							<given-names>RD</given-names>
						</name>
					</person-group>
					<source>Pharmacology of neuromuscular blocking drugs. Miller's anesthesia</source>
					<edition>8</edition>
					<publisher-name>Elsevier</publisher-name>
					<publisher-loc>Canada</publisher-loc>
					<year>2015</year>
				</element-citation>
			</ref>
			<ref id="B10">
				<label>10</label>
				<mixed-citation>10. Ewan PW, Dugué P, Mirakian R, et al. BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clin Exp Allergy 2010;40:15-31.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ewan</surname>
							<given-names>PW</given-names>
						</name>
						<name>
							<surname>Dugué</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Mirakian</surname>
							<given-names>R</given-names>
						</name>
					</person-group>
					<article-title>BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia</article-title>
					<source>Clin Exp Allergy</source>
					<year>2010</year>
					<volume>40</volume>
					<fpage>15</fpage>
					<lpage>31</lpage>
				</element-citation>
			</ref>
			<ref id="B11">
				<label>11</label>
				<mixed-citation>11. Aguilera-Castro F. Intraoperative recurrence of probable allergic reaction to remifentanil. Case report. Rev Colomb Anestesiol 2017;45 (s1):31-35.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Aguilera-Castro</surname>
							<given-names>F</given-names>
						</name>
					</person-group>
					<article-title>Intraoperative recurrence of probable allergic reaction to remifentanil Case report</article-title>
					<source>Rev Colomb Anestesiol</source>
					<year>2017</year>
					<volume>45</volume>
					<issue>s1</issue>
					<fpage>31</fpage>
					<lpage>35</lpage>
				</element-citation>
			</ref>
			<ref id="B12">
				<label>12</label>
				<mixed-citation>12. Holloway K, Green T. Comités de Farmacoterapia. Guía Práctica. OMS. Departamento de Medicamentos Esenciales y Política Farmacéutica, Francia:2003.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Holloway</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Green</surname>
							<given-names>T</given-names>
						</name>
					</person-group>
					<source>Comités de Farmacoterapia</source>
					<comment>Guía Práctica</comment>
					<publisher-name>OMS. Departamento de Medicamentos Esenciales y Política Farmacéutica</publisher-name>
					<publisher-loc>Francia</publisher-loc>
					<year>2003</year>
				</element-citation>
			</ref>
			<ref id="B13">
				<label>13</label>
				<mixed-citation>13. Caimmi S, Caimmi D, Cardinale F, et al. Perioperative allergy: uncommon agents. Int J Immunopathol Pharmacol 2011;24 (3 suppl):S61-S68.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Caimmi</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Caimmi</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Cardinale</surname>
							<given-names>F</given-names>
						</name>
					</person-group>
					<article-title>Perioperative allergy uncommon agents</article-title>
					<source>Int J Immunopathol Pharmacol</source>
					<year>2011</year>
					<volume>24</volume>
					<issue>3 Suppl</issue>
					<fpage>S61</fpage>
					<lpage>S68</lpage>
				</element-citation>
			</ref>
			<ref id="B14">
				<label>14</label>
				<mixed-citation>14. Dewachter P, Mouton-Faivre C, Emala CW. Anaphylaxis and anesthesia: controversies and new insights. Anesthesiology 2009;111:1141-1150.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Dewachter</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Mouton-Faivre</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Emala</surname>
							<given-names>CW</given-names>
						</name>
					</person-group>
					<article-title>Anaphylaxis and anesthesia controversies and new insights</article-title>
					<source>Anesthesiology</source>
					<year>2009</year>
					<volume>111</volume>
					<fpage>1141</fpage>
					<lpage>1150</lpage>
				</element-citation>
			</ref>
			<ref id="B15">
				<label>15</label>
				<mixed-citation>15. Pedersen AF, Green S, Rose MA. Failure to investigate anaesthetic anaphylaxis resulting in a preventable second anaphylactic reaction. Anaesth Intensive Care 2012;40:1053-1055.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Pedersen</surname>
							<given-names>AF</given-names>
						</name>
						<name>
							<surname>Green</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Rose</surname>
							<given-names>MA</given-names>
						</name>
					</person-group>
					<article-title>Failure to investigate anaesthetic anaphylaxis resulting in a preventable second anaphylactic reaction</article-title>
					<source>Anaesth Intensive Care</source>
					<year>2012</year>
					<volume>40</volume>
					<fpage>1053</fpage>
					<lpage>1055</lpage>
				</element-citation>
			</ref>
			<ref id="B16">
				<label>16</label>
				<mixed-citation>16. Berroa F, Lafuente A, Javaloyes G, et al. The incidence of perioperative hypersensitivity reactions: a single-center, prospective, cohort study. Anesth Analg 2015;121:117-123.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Berroa</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Lafuente</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Javaloyes</surname>
							<given-names>G</given-names>
						</name>
					</person-group>
					<article-title>The incidence of perioperative hypersensitivity reactions a single-center, prospective, cohort study</article-title>
					<source>Anesth Analg</source>
					<year>2015</year>
					<volume>121</volume>
					<fpage>117</fpage>
					<lpage>123</lpage>
				</element-citation>
			</ref>
			<ref id="B17">
				<label>17</label>
				<mixed-citation>17. Bevilacqua-Alén E, Illodo-Miramontes G, López-González JM, et al. Anesthetic management of muscle relaxant allergy. Rev Argent Anestesiol 2017;75:7-12.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Bevilacqua-Alén</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Illodo-Miramontes</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>López-González</surname>
							<given-names>JM</given-names>
						</name>
					</person-group>
					<article-title>Anesthetic management of muscle relaxant allergy</article-title>
					<source>Rev Argent Anestesiol</source>
					<year>2017</year>
					<volume>75</volume>
					<fpage>7</fpage>
					<lpage>12</lpage>
				</element-citation>
			</ref>
			<ref id="B18">
				<label>18</label>
				<mixed-citation>18. Callaway CW, Soar J, Aibiki M, et al. Part 4: advanced life support: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation 2015;132 (16 suppl 1):S84-S145.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Callaway</surname>
							<given-names>CW</given-names>
						</name>
						<name>
							<surname>Soar</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Aibiki</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>Part 4 advanced life support: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations</article-title>
					<source>Circulation</source>
					<year>2015</year>
					<volume>132</volume>
					<issue>16 Suppl 1</issue>
					<fpage>S84</fpage>
					<lpage>S145</lpage>
				</element-citation>
			</ref>
			<ref id="B19">
				<label>19</label>
				<mixed-citation>19. McEvoy MD, Thies KC, Einav S, et al. Cardiac arrest in the operating room: Part 2-Special situations in the perioperative period. Anesth Analg 2018;126:889-903.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>McEvoy</surname>
							<given-names>MD</given-names>
						</name>
						<name>
							<surname>Thies</surname>
							<given-names>KC</given-names>
						</name>
						<name>
							<surname>Einav</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<article-title>Cardiac arrest in the operating room Part 2-Special situations in the perioperative period</article-title>
					<source>Anesth Analg</source>
					<year>2018</year>
					<volume>126</volume>
					<fpage>889</fpage>
					<lpage>903</lpage>
				</element-citation>
			</ref>
			<ref id="B20">
				<label>20</label>
				<mixed-citation>20. Johnson KM, Lehman RE. Acute management of the obstructed endotracheal tube. Respir Care 2012;57:1342-1344.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Johnson</surname>
							<given-names>KM</given-names>
						</name>
						<name>
							<surname>Lehman</surname>
							<given-names>RE</given-names>
						</name>
					</person-group>
					<article-title>Acute management of the obstructed endotracheal tube</article-title>
					<source>Respir Care</source>
					<year>2012</year>
					<volume>57</volume>
					<fpage>1342</fpage>
					<lpage>1344</lpage>
				</element-citation>
			</ref>
		</ref-list>
		<fn-group>
			<fn fn-type="other" id="fn1">
				<label>How to cite this article:</label>
				<p> Ramirez-Gonzales R, Del-Castillo-Gervasi RA, Shiraishi-Zapata CJ, Laurencio-Ambrosio JN. Two probable anaphylactic events during consecutive cranial surgeries: case report. Colombian Journal of Anesthesiology. 2018;46:322-326.</p>
			</fn>
			<fn fn-type="other" id="fn2">
				<label>Funding</label>
				<p> The authors did not receive any financial contributions for this article.</p>
			</fn>
			<fn fn-type="other" id="fn3">
				<label>Conflicts of interest</label>
				<p> The authors have no conflict of interest to disclose.</p>
			</fn>
		</fn-group>
	</back>
	<!--sub-article article-type="translation" id="s1" xml:lang="es">
		<front-stub>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Reporte de casos</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Dos probables eventos de anafilaxia durante cirugías craneales consecutivas. Reporte de caso</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Ramirez-Gonzales</surname>
						<given-names>Rafael</given-names>
					</name>
					<xref ref-type="aff" rid="aff3"><sup>a</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Del-Castillo-Gervasi</surname>
						<given-names>Román Augusto</given-names>
					</name>
					<xref ref-type="aff" rid="aff3"><sup>a</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Shiraishi-Zapata</surname>
						<given-names>Carlos Javier</given-names>
					</name>
					<xref ref-type="aff" rid="aff4"><sup>b</sup></xref>
					<xref ref-type="corresp" rid="c2"><sup>*</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Laurencio-Ambrosio</surname>
						<given-names>John Neper</given-names>
					</name>
					<xref ref-type="aff" rid="aff3"><sup>a</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff3">
				<label>a</label>
				<institution content-type="original"> Departamento de Anestesiología y Centro Quirúrgico, Hospital María Auxiliadora, Ministerio de Salud, Lima, Peru.</institution>
			</aff>
			<aff id="aff4">
				<label>b</label>
				<institution content-type="original"> Servicio de Centro Quirurgico y Anestesiología, Hospital EsSalud, Talara, Peni.</institution>
			</aff>
			<author-notes>
				<corresp id="c2"><sup>*</sup> Correspondencia: Avenida Panamericana s/n Pariñas, Servicio de Centro Quirurgico y Anestesiología, Hospital EsSalud. Talara, Peru. Correo electrónico: Shiraishi52@hotmail.com</corresp>
			</author-notes>
			<abstract>
				<title>Resumen</title>
				<p>La anafilaxia perioperatoria representa un diagnóstico problemático porque posee manifestaciones clínicas de distinta intensidad y comunes a otras patologías. Reportamos el caso de un paciente que presentó dos probables eventos de anafilaxia durante cirugías craneales consecutivas bajo anestesia general, cuyo agente causal no pudo ser confirmado. La investigación de estas reacciones es crucial para identificar los agentes causales y evitar reacciones de mayor severidad en futuras exposiciones.</p>
			</abstract>
			<kwd-group xml:lang="es">
				<title>Palabras clave:</title>
				<kwd>Anestesia</kwd>
				<kwd>Anafilaxia</kwd>
				<kwd>Paro Cardíaco</kwd>
				<kwd>Reanimación</kwd>
			</kwd-group>
		</front-stub>
		<body>
			<sec sec-type="intro">
				<title>Introducción</title>
				<p>La anafilaxia es una reacción de hipersensibilidad (RH) sistémica severa que amenaza la vida.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref> La anafilaxia perioperatoria figura entre las principales causas de complicaciones anestésicas, con una incidencia entre 1/ 1250 a 1/18,600 procedimientos y tasas de mortalidad entre 4% y 4.7% (anafilaxia farmacológica).<xref ref-type="bibr" rid="B2"><sup>2</sup></xref> Se origina por la liberación debida a un estímulo de mediadores bioactivos de mastocitos y basófilos en dos o más sistemas del organismo, que producen permeabilidad capilar aumentada, vasodilatación, broncoconstricción e hipotensión.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref>
				</p>
				<p>La anafilaxia intraoperatoria representa un diagnóstico complicado pues varios síntomas no pueden ser evaluados en un paciente sedado o inconsciente, los signos cutáneos están ocultos por campos quirúrgicos y existe administración simultánea de varios fármacos.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B4"><sup>4</sup></xref> El 90% de casos aparecen en la inducción, aunque también existen reacciones tardías, y la sintomatología varía en intensidad, desde reacciones de hipersensibilidad leves con predominio de manifestaciones cutáneas (grado I) hasta parada cardíaca y/o respiratoria (grado IV).<xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref> Pueden ser confundidas con otra patología si hubiera un único síntoma, originando un diagnóstico incorrecto, la ausencia de evaluación por alergología, y el riesgo de una nueva exposición, potencialmente mortal, al agente implicado.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref>
				</p>
				<p>Los signos más frecuentes durante reacciones severas son la ausencia de pulso, dificultad en la ventilación por broncoespasmo, desaturación, e incluso como primera manifestación puede aparecer un colapso cardiovascular o parada cardiaca.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref> Se ha citado de valor diagnóstico la disminución del dióxido de carbono al final de la espiración (ETCO<sub>2</sub>) por debajo de 20mmHg.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref>
				</p>
				<sec>
					<title>Información del paciente</title>
					<p>Paciente de sexo masculino de 44 años, procedencia rural, hospitalizado en la unidad de cuidados intermedios (UCIN) luego del alta en la unidad de cuidados intensivos (UCI) por evento de taquicardia supraventricular (TSV) durante una cirugía craneal electiva que ocasionó su suspensión. (Ver <xref ref-type="table" rid="t4">Tabla 1</xref>). Presentaba leve hemiparesia derecha en el examen clínico. La evaluación cardiológica solicitada no halló ninguna alteración y concluyó que la TSV fue originada por manipulación quirúrgica o reflejo autonómico. Se prescribió 10 mgr de Propanolol b.i.d. y se le asignó a la clase 2 del índice de Goldman. Durante la evaluación anestésica manifestó no padecer alergias (medicamentos o alimentos); así, se le asignó a la clase 2 de la escala ASA y fue reprogramado.</p>
					<p>
						<table-wrap id="t4">
							<label>Tabla 1</label>
							<caption>
								<title>Calendario.</title>
							</caption>
							<graphic xlink:href="0120-3347-rca-46-04-322-gt4.png"/>
							<table-wrap-foot>
								<fn id="TFN7">
									<p>CD=(Craniectomía descompresiva), TEC=(traumatismo encéfalo-craneano), UCI=(unidad de cuidados intensivos), CP=(craneoplastía), TSV=(taquicardia supraventricular), UCIN=(unidad de cuidados intermedios), AESP=(actividad eléctrica sin pulso), RCP=(reanimación cardiopulmonar), URPA=(unidad de reanimación post-anestésica).</p>
								</fn>
								<fn id="TFN8">
									<p>Fuente: Autores.</p>
								</fn>
							</table-wrap-foot>
						</table-wrap>
					</p>
				</sec>
				<sec>
					<title>Hallazgos clínicos</title>
					<p>Ingresó a quirófano con funciones vitales normales y 95 kilogramos de peso. Se indujo anestesia general balanceada (<xref ref-type="table" rid="t4">tablas 1</xref> y <xref ref-type="table" rid="t5">2</xref>) y se realizó intubación endotraqueal con tubo anillado N° 8.5 (TET). Se inició la cirugía con 99% de saturación de oxígeno (SaO<sub>2</sub>) y 30 mmHg de ETCO<sub>2</sub>. Las funciones vitales fueron normales durante el mantenimiento. Una hora después de la inducción, de forma subita y sin alteraciones previas en la presión arterial (hipotensión) y frecuencia cardíaca (bradicardia), se detectaron disminuciones sostenidas y progresivas de ETCO<sub>2</sub> y SaO<sub>2</sub> (hasta 24 mmHg y 92% respectivamente).</p>
					<p>
						<table-wrap id="t5">
							<label>Tabla 2</label>
							<caption>
								<title>Listado detallado de fármacos utilizados en las tres cirugías.</title>
							</caption>
							<graphic xlink:href="0120-3347-rca-46-04-322-gt5.png"/>
							<table-wrap-foot>
								<fn id="TFN9">
									<p>CD=(Craniectomía descompresiva), CP=(Craneoplastía), TSV=(Taquicardia supraventricular), AESP=(Actividad eléctrica sin pulso).</p>
								</fn>
								<fn id="TFN10">
									<p>Fuente: Autores.</p>
								</fn>
							</table-wrap-foot>
						</table-wrap>
					</p>
				</sec>
				<sec>
					<title>Evaluación diagnóstica</title>
					<p>Debido a las alteraciones en la ETCO<sub>2</sub> y SaO<sub>2</sub>, inicialmente se descartó el malfuncionamiento del TET. Inmediatamente después se detectó la ausencia de pulso palpable y TSV en el monitor multiparámetros, signos de actividad eléctrica sin pulso (AESP). Además, al retirar los campos quirúrgicos, se evidenció un eritema generalizado. En consecuencia, se diagnosticó una probable anafilaxia grado IV.</p>
				</sec>
				<sec>
					<title>Intervención terapéutica</title>
					<p>Se inició reanimación cardiopulmonar (RCP) avanzada con compresiones torácicas continuas, administración de 1 mgr de adrenalina EV y ventilación manual. Dos minutos después, hubo retorno espontáneo de la circulación (ROSC), por lo que las compresiones se suspendieron. Sin embargo, se reanudaron un minuto después por fibrilación ventricular (FV) que requirió descarga bifásica de 200 joules. Se administró una segunda dosis de adrenalina. Hubo recurrencia de la FV en 3 oportunidades, las cuales recibieron el mismo tratamiento. Después de 2 minutos, se comprobó ROSC y se colocó un catéter venoso central subclavio y un catéter arterial radial.</p>
				</sec>
				<sec>
					<title>Seguimiento y resultados</title>
					<p>Ingresó a URPA con 70/50 mmHg de presión arterial invasiva, 130 latidos/minuto, 90% de SaO<sub>2</sub>, una presión venosa central de 10cmH<sub>2</sub>O, bajo ventilación mecánica controlada por volumen y Dopamina a dosis regulable. Se administraron 250 mgr de Hidrocortisona t.i.d. Diez horas después de la AESP, fue extubado sin complicaciones, y 15 horas después presentaba 14 puntos en la escala de Glasgow. Fue hospitalizado en UCIN, donde tres días después se retiró la dopamina. Seis días después de AESP pasó a pabellón general, donde recibió el alta.</p>
				</sec>
			</sec>
			<sec sec-type="discussion">
				<title>Discusión</title>
				<p>La evaluación en UCIN se enfocó en la TSV causante de la suspensión, porque inicialmente se sospechó una patología cardiológica. Sin embargo, la historia clínica consignaba que ingresó a UCI en el postoperatorio inmediato por Shock distributivo por anafilaxia secundaria a reacción adversa farmacológica (RAM) con hipotensión y eritema generalizado. Así, clínicamente este primer evento correspondió a una probable anafilaxia grado III.</p>
				<p>La principal causa de las RH perioperatorias son los relajantes neuromusculares (RNMs) (50% a 70%), seguidos del látex (12% a 16.7%), y los antibióticos (15%).<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref> Si revisamos el rol de los fármacos administrados en estas cirugías en las RH inmediatas (<xref ref-type="table" rid="t2">Tabla 2</xref>), se aprecia que Tiopental sódico se implicó frecuentemente en ellas (incidencia 1:30 000), aunque Propofol también puede causarlas. Midazolam (suministrado en 2 cirugías) y Fentanilo (suministrado en todas) raramente las desencadenan.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref>
				</p>
				<p>Se utilizaron dos compuestos esteroideos monocuaternarios (Rocuronio y Vecuronio), que poseen iones de amonio sustituidos. Estos iones constituyen sitios aler-génicos involucrados en el reconocimiento específico de IgE, lo cual explicaría la reactividad cruzada (RC) en pruebas cutáneas hallada en 60-70% de pacientes alérgicos a RNMs. La RC a todos los relajantes es más común cuando un compuesto esteroideo causó la reacción inicial. También hubo RH en pacientes nunca expuestos a RNMs porque ocurre RC con cosméticos, alimentos y desinfectantes.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref>
				</p>
				<p>Otros agentes causantes de anafilaxia intraoperatoria tardía son la povidona yodada y clorhexidina.<xref ref-type="bibr" rid="B10"><sup>10</sup></xref> En un informe previo<xref ref-type="bibr" rid="B11"><sup>11</sup></xref> el algoritmo de Naranjo permitió evaluar la causalidad de una RAM. Este algoritmo permitió analizar la segunda RH, donde hubo una puntuación de 5 para el relajante y povidona, lo que los convierte en probables agentes de la RAM.<xref ref-type="bibr" rid="B12"><sup>12</sup></xref> Considerando que se reportaron escasos casos por povidona tópica, el RNM sería el probable agente causal.<xref ref-type="bibr" rid="B13"><sup>13</sup></xref>
				</p>
				<p>La investigación de la causa de una anafilaxia puede ser problemática, pues varios agentes pudieran asociarse a ella.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref> Se han descrito 3 evidencias necesarias (historia clínica, valoración biológica y pruebas cutáneas).<xref ref-type="bibr" rid="B14"><sup>14</sup></xref> La valoración biológica determina la presencia de un mecanismo alérgico en la reacción mediante pruebas de laboratorio tempranas (triptasa sérica total e histamina plasmática) y tardías (pruebas de punción cutánea, activación de basóilos, de provocación e inmunoensayos de IgE específica).<xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B14"><sup>14</sup></xref> En estos dos probables eventos de anafilaxia sólo hubo evidencia clínica. Asimismo, se desconoce si existían en nuestro medio las otras pruebas requeridas en la fecha de presentación.</p>
				<p>La situación clave fue la desatención de la primera RH, pues el paciente debió ser evaluado por Alergología y no haberse reprogramado hasta la identificación del agente implicado. Lo anterior produjo una nueva exposición al agente con una reacción prevenible más severa.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B15"><sup>15</sup></xref> Así, toda reacción perioperatoria debe investigarse para ofrecer seguridad en los procedimientos anestésicos futuros porque incluso reacciones leves pueden ser causadas por hipersensibilidad y pudieran ser desatendidas o atribuidas a reacciones inespecíficas.<xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref>
				</p>
				<p>Algunos aspectos terapéuticos de estas probables RH pudieran ser optimizados, como administrar retos de fluidos intravenosos, Clorfenamina y Amiodarona (para evitar la recurrencia de FV).<xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref> (<xref ref-type="table" rid="t6">Tabla 3</xref>) Además, se ha descrito la utilidad de la nemotecnia DOPE para resolver el deterioro del paciente en ventilación mecánica.<xref ref-type="bibr" rid="B20"><sup>20</sup></xref>
				</p>
				<p>
					<table-wrap id="t6">
						<label>Tabla 3</label>
						<caption>
							<title>Diagnóstico diferencial y manejo de anafilaxia perioperatoria en el adulto.</title>
						</caption>
						<graphic xlink:href="0120-3347-rca-46-04-322-gt6.png"/>
						<table-wrap-foot>
							<fn id="TFN11">
								<p>Fuentes: Adaptada de Chapman J y Lalkhen AG,<xref ref-type="bibr" rid="B1"><sup>1</sup></xref> Mertes et al.,<xref ref-type="bibr" rid="B6"><sup>6</sup></xref> McEvoy et al.<xref ref-type="bibr" rid="B19"><sup>19</sup></xref> Abreviaturas: FIO<sub>2</sub> (fracción inspiratoria de oxígeno), PEEP (presión positiva al final de la espiración), RCP (reanimación cardiopulmonar), ROSC (retorno espontáneo de la circulación).</p>
							</fn>
							<fn id="TFN12">
								<p>Fuente: Autores.</p>
							</fn>
						</table-wrap-foot>
					</table-wrap>
				</p>
				<p>Posteriormente a una RH, el anestesiólogo debe solicitar pruebas de laboratorio que contribuyan al diagnóstico clínico, e interconsultar a Alergología para la investigación del agente causal. Asimismo, actualmente todos los servicios peruanos de anestesiología cuentan con un registro obligatorio de eventos adversos. Finalmente, el reconocimiento temprano de la alteración de ETC0<sub>2</sub> y Sa0<sub>2</sub> permitió instaurar medidas oportunas de RCP para evitar un desenlace fatal.</p>
			</sec>
			<sec>
				<title>Perspectiva del paciente</title>
				<p>No hubo consultas anestesiológicas de seguimiento para proveer un informe farmacológico detallado escrito al paciente. Asimismo, no se conoce el resultado de su evaluación alergológica.</p>
			</sec>
			<sec>
				<title>Consentimiento informado</title>
				<p>El Comité de Ética Hospitalario aprobó la publicación del informe de caso porque el paciente no reside en la jurisdicción hospitalaria para obtener un consentimiento escrito.</p>
			</sec>
			<sec>
				<title>Responsabilidades éticas</title>
				<p>Protección de personas y animales. Los autores declaran que los procedimientos seguidos se conformaron a las normas éticas del comité de experimentación humana responsable y de acuerdo con la Asociación Médica Mundial y la Declaración de Helsinki.</p>
				<p>Confidencialidad de los datos. Los autores declaran que han seguido los protocolos de su centro de trabajo sobre la publicación de datos de pacientes.</p>
				<p>Derecho a la privacidad y consentimiento informado. Los autores han obtenido el consentimiento informado de los pacientes y/o sujetos referidos en el artículo. Este documento obra en poder del autor de correspondencia.</p>
			</sec>
			<sec>
				<title>Financiamiento</title>
				<p>Los autores no recibieron patrocinio para realizar el artículo.</p>
			</sec>
			<sec>
				<title>Conflicto de intereses</title>
				<p>Los autores declaran no tener conflictos de intereses.</p>
			</sec>
		</body>
		<back>
			<fn-group>
				<fn fn-type="other" id="fn4">
					<label>Cómo citar este artículo:</label>
					<p> Ramirez-Gonzales R, Del-Castillo-Gervasi RA, Shiraishi-Zapata CJ, Laurencio-Ambrosio JN. Two probable anaphylactic events during consecutive cranial surgeries: case report. Colombian Journal of Anesthesiology. 2018;46:322-326.</p>
				</fn>
			</fn-group>
		</back>
	</sub-article-->
</article>